Nebula Genomics is looking to brand itself as a leader in an rapidly-growing genomics market, as well as reduce overall costs for consumers.
According to a whitepaper published by the company early February, the company says more widely-adopted genome sequencing would be a game changer.
” … If genomic data is shared with researchers, the causes of many diseases will be identified and new drugs developed,” according to the whitepaper. “These opportunities are creating a genomic data market worth billions of dollars.”
Nebula Genomics says it will “spur genomic data growth by significantly reducing the costs of personal genome sequencing.”
“We will accomplish this through decentralization, cryptography and utilization of the blockchain,” the whitepaper says.
The company looks to develop a system in which the owners of genomics data can sell directly to data buyers and earn “sequencing subsidies” to profit from sharing their data, which could pull down costs significantly.